Synopsys (NASDAQ:SNPS) Stock Rep. Julie Johnson

Key Points

• Representative Julie Johnson purchased between $1,001 and $15,000 in shares of Synopsys, Inc. (NASDAQ:SNPS) on July 18th, as disclosed in a filing dated August 14th.
• Synopsys reported a 10.3% increase in revenue, with $1.60 billion for the quarter and EPS of $3.67, surpassing analysts' expectations.
• Recent analyst reports resulted in several rating upgrades for Synopsys, with price targets from institutions like Bank of America and Morgan Stanley reflecting strong future growth potential.

Representative Julie Johnson (D-Texas) recently bought shares of Synopsys, Inc. NASDAQ: SNPS. In a filing disclosed on August 14th, the Representative disclosed that they had bought between $1,001 and $15,000 in Synopsys stock on July 18th. The trade occurred in the Representative's "MERRILL LYNCH TAX EFFICIENT CORE" account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Seagate Technology NASDAQ: STX on 7/29/2025.
• Sold $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 7/29/2025.
• Purchased $1,001 - $15,000 in shares of Packaging Corporation of America NYSE: PKG on 7/25/2025.
• Purchased $1,001 - $15,000 in shares of Chevron NYSE: CVX on 7/25/2025.
• Sold $1,001 - $15,000 in shares of Parker-Hannifin NYSE: PH on 7/25/2025.
• Sold $1,001 - $15,000 in shares of Exxon Mobil NYSE: XOM on 7/25/2025.
• Sold $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 7/24/2025.
• Sold $1,001 - $15,000 in shares of Philip Morris International NYSE: PM on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of CME Group NASDAQ: CME on 7/22/2025.
• Sold $1,001 - $15,000 in shares of BlackRock NYSE: BLK on 7/22/2025.

Synopsys Price Performance

NASDAQ SNPS traded down $12.54 during trading on Tuesday, hitting $612.79. 1,170,182 shares of the stock traded hands, compared to its average volume of 1,430,034. The company has a market capitalization of $95.08 billion, a P/E ratio of 44.24, a price-to-earnings-growth ratio of 4.14 and a beta of 1.15. The firm has a 50-day simple moving average of $563.66 and a 200-day simple moving average of $499.14. The company has a quick ratio of 6.85, a current ratio of 7.02 and a debt-to-equity ratio of 1.01. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73.

Synopsys (NASDAQ:SNPS - Get Free Report) last announced its earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 EPS for the quarter, topping analysts' consensus estimates of $3.40 by $0.27. Synopsys had a return on equity of 17.09% and a net margin of 34.77%.The firm had revenue of $1.60 billion during the quarter, compared to analysts' expectations of $1.60 billion. During the same quarter in the previous year, the business earned $3.00 EPS. The company's quarterly revenue was up 10.3% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. As a group, analysts predict that Synopsys, Inc. will post 10.64 EPS for the current year.

Insider Buying and Selling at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 7,310 shares of the business's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $485.72, for a total transaction of $3,550,613.20. Following the sale, the chief financial officer owned 15,291 shares in the company, valued at approximately $7,427,144.52. The trade was a 32.34% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $457.93, for a total value of $5,204,832.38. Following the sale, the chief executive officer owned 71,589 shares in the company, valued at approximately $32,782,750.77. The trade was a 13.70% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 27,686 shares of company stock worth $13,001,048. 0.62% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

SNPS has been the subject of a number of research analyst reports. Piper Sandler lifted their target price on Synopsys from $615.00 to $660.00 and gave the company an "overweight" rating in a research report on Monday, July 21st. Needham & Company LLC reaffirmed a "buy" rating and set a $660.00 target price (up from $650.00) on shares of Synopsys in a research report on Tuesday, July 15th. KeyCorp lifted their target price on Synopsys from $540.00 to $610.00 and gave the company an "overweight" rating in a research report on Thursday, July 10th. Rosenblatt Securities lifted their target price on Synopsys from $625.00 to $650.00 and gave the company a "buy" rating in a research report on Friday, July 25th. Finally, Morgan Stanley reaffirmed an "overweight" rating and set a $715.00 target price (up from $540.00) on shares of Synopsys in a research report on Monday, August 11th. Thirteen investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $630.67.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in SNPS. Lionshead Wealth Management LLC increased its position in Synopsys by 1.9% during the 2nd quarter. Lionshead Wealth Management LLC now owns 914 shares of the semiconductor company's stock valued at $469,000 after buying an additional 17 shares in the last quarter. YANKCOM Partnership grew its stake in Synopsys by 3.3% during the 2nd quarter. YANKCOM Partnership now owns 537 shares of the semiconductor company's stock valued at $275,000 after purchasing an additional 17 shares during the last quarter. Manchester Capital Management LLC grew its stake in Synopsys by 5.3% during the 2nd quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company's stock valued at $174,000 after purchasing an additional 17 shares during the last quarter. Hemington Wealth Management grew its stake in Synopsys by 10.1% during the 2nd quarter. Hemington Wealth Management now owns 197 shares of the semiconductor company's stock valued at $100,000 after purchasing an additional 18 shares during the last quarter. Finally, Concord Asset Management LLC VA grew its stake in Synopsys by 0.8% during the 2nd quarter. Concord Asset Management LLC VA now owns 2,379 shares of the semiconductor company's stock valued at $1,220,000 after purchasing an additional 18 shares during the last quarter. 85.47% of the stock is owned by institutional investors.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas' 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. Johnson (Democratic Party) ran for election to the U.S. House to represent Texas' 32nd Congressional District. She won in the general election on November 5, 2024. Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson's career experience includes working as an attorney.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.